AllSquare Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $63.1K | Hold |
1,400
| – | – | 0.03% | 212 |
|
|
2025
Q2 | $64.8K | Hold |
1,400
| – | – | 0.04% | 198 |
|
|
2025
Q1 | $85.4K | Hold |
1,400
| – | – | 0.05% | 160 |
|
|
2024
Q4 | $79.2K | Hold |
1,400
| – | – | 0.05% | 170 |
|
|
2024
Q3 | $72.4K | Sell |
1,400
-1,000
| -42% | -$46.9K | 0.04% | 177 |
|
|
2024
Q2 | $99.7K | Sell |
2,400
-2,646
| -52% | -$118K | 0.06% | 144 |
|
|
2024
Q1 | $274K | Sell |
5,046
-2,050
| -29% | -$104K | 0.16% | 85 |
|
|
2023
Q4 | $364K | Sell |
7,096
-400
| -5% | -$21K | 0.22% | 63 |
|
|
2023
Q3 | $435K | Hold |
7,496
| – | – | 0.28% | 51 |
|
|
2023
Q2 | $478K | Sell |
7,496
-100
| -1% | -$6.71K | 0.31% | 49 |
|
|
2023
Q1 | $526K | Buy |
7,596
+21
| +0.3% | +$1.48K | 0.34% | 41 |
|
|
2022
Q4 | $545K | Hold |
7,575
| – | – | 0.37% | 39 |
|
|
2022
Q3 | $539K | Buy |
7,575
+725
| +11% | +$52.6K | 0.39% | 37 |
|
|
2022
Q2 | $527K | Hold |
6,850
| – | – | 0.36% | 41 |
|
|
2022
Q1 | $500K | Hold |
6,850
| – | – | 0.3% | 49 |
|
|
2021
Q4 | $427K | Sell |
6,850
-200
| -3% | -$11.7K | 0.25% | 56 |
|
|
2021
Q3 | $417K | Sell |
7,050
-709
| -9% | -$46.7K | 0.25% | 50 |
|
|
2021
Q2 | $518K | Buy |
7,759
+300
| +4% | +$19.6K | 0.3% | 45 |
|
|
2021
Q1 | $471K | Buy |
7,459
+6,466
| +651% | +$402K | 0.29% | 47 |
|
|
2020
Q4 | $62K | Hold |
993
| – | – | 0.04% | 180 |
|
|
2020
Q3 | $60K | Buy |
993
+41
| +4% | +$2.47K | 0.04% | 173 |
|
|
2020
Q2 | $56K | Hold |
952
| – | – | 0.04% | 170 |
|
|
2020
Q1 | $53K | Hold |
952
| – | – | 0.05% | 153 |
|
|
2019
Q4 | $61K | Sell |
952
-164
| -15% | -$9.39K | 0.04% | 166 |
|
|
2019
Q3 | $57K | Hold |
1,116
| – | – | 0.04% | 167 |
|
|
2019
Q2 | $51K | Buy |
1,116
+111
| +11% | +$5.17K | 0.04% | 186 |
|
|
2019
Q1 | $48K | Hold |
1,005
| – | – | 0.04% | 190 |
|
|
2018
Q4 | $52K | Sell |
1,005
-1,907
| -65% | -$102K | 0.04% | 159 |
|
|
2018
Q3 | $181K | Buy |
2,912
+512
| +21% | +$30.4K | 0.14% | 86 |
|
|
2018
Q2 | $133K | Hold |
2,400
| – | – | 0.1% | 106 |
|
|
2018
Q1 | $152K | Buy |
2,400
+300
| +14% | +$19.3K | 0.12% | 84 |
|
|
2017
Q4 | $129K | Hold |
2,100
| – | – | 0.1% | 92 |
|
|
2017
Q3 | $134K | Buy |
+2,100
| New | +$123K | 0.11% | 85 |
|
|
2017
Q2 | – | Sell |
-2,100
| Closed | -$114K | – | 186 |
|
|
2017
Q1 | $114K | Sell |
2,100
-552
| -21% | -$30.3K | 0.1% | 87 |
|
|
2016
Q4 | $155K | Buy |
2,652
+50
| +2% | +$2.73K | 0.14% | 73 |
|
|
2016
Q3 | $140K | Buy |
2,602
+150
| +6% | +$9.63K | 0.13% | 66 |
|
|
2016
Q2 | $180K | Hold |
2,452
| – | – | 0.18% | 54 |
|
|
2016
Q1 | $157K | Hold |
2,452
| – | – | 0.16% | 57 |
|
|
2015
Q4 | $169K | Buy |
2,452
+8
| +0.3% | +$529 | 0.17% | 56 |
|
|
2015
Q3 | $145K | Hold |
2,444
| – | – | 0.15% | 58 |
|
|
2015
Q2 | $163K | Hold |
2,444
| – | – | 0.15% | 60 |
|
|
2015
Q1 | $158K | Buy |
2,444
+115
| +5% | +$7.2K | 0.15% | 62 |
|
|
2014
Q4 | $137K | Buy |
+2,329
| New | +$131K | 0.13% | 65 |
|
Other funds holding BMY
AllSquare Wealth Management's BMY Position: Q3 2025 in Review
AllSquare Wealth Management held its Bristol-Myers Squibb (BMY) position steady in Q3 2025 at 1,400 shares worth $63.1K. The position accounts for 0.03% of the portfolio, ranked #212.
AllSquare Wealth Management first reported a position in BMY in Q4 2014 and has held it in 43 quarters since. The position peaked at $545K in Q4 2022. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.
- AllSquare Wealth Management held 1,400 shares of Bristol-Myers Squibb worth $63.1K as of Q3 2025.
- AllSquare Wealth Management left its Bristol-Myers Squibb share count unchanged in Q3 2025.
- Bristol-Myers Squibb made up 0.03% of AllSquare Wealth Management's portfolio in Q3 2025, its #212 holding.
- AllSquare Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 43 quarters since.
- AllSquare Wealth Management's Bristol-Myers Squibb position peaked at $545K in Q4 2022.
- 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.
Based on AllSquare Wealth Management's 13F filing for Q3 2025, filed 12 Jan 2026.